Dorzagliatin-话题@MedSci

#Dorzagliatin#

3篇内容 | 873人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=896333, encodeId=4129896333b5, content=<a href='/topic/show?id=e86c6193ea' target=_blank style='color:#2F92EE;'>#Dorzagliatin#</a>, objectTitle=Lancet Diabetes Endo：国产II型糖尿病新药临床效果显著, objectType=article, longId=137509, objectId=01d113e5099f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201805/20180508101132628.jpg, objectUrl=/article/show_article.do?id=01d113e5099f, replyNumber=0, likeNumber=108, createdTime=2020-11-02, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01d113e5099f, moduleTitle=Lancet Diabetes Endo：国产II型糖尿病新药临床效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01d113e5099f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=896332, encodeId=99c58963324b, content=<a href='/topic/show?id=e86c6193ea' target=_blank style='color:#2F92EE;'>#Dorzagliatin#</a>, objectTitle=中国糖尿病创新药Dorzagliatin达到3期临床主要疗效终点，可降低HbA1c 1.07%, objectType=article, longId=182879, objectId=7aba1828e9ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201911/20191112165927233.png, objectUrl=/article/show_article.do?id=7aba1828e9ca, replyNumber=0, likeNumber=119, createdTime=2020-11-02, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aba1828e9ca, moduleTitle=中国糖尿病创新药Dorzagliatin达到3期临床主要疗效终点，可降低HbA1c 1.07%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aba1828e9ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=896330, encodeId=9297896330ca, content=<a href='/topic/show?id=e86c6193ea' target=_blank style='color:#2F92EE;'>#Dorzagliatin#</a>单药治疗<a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a>, objectTitle=III期临床试验证明：Dorzagliatin单药治疗2型糖尿病疗效确切, objectType=article, longId=196105, objectId=041919610548, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020618/1592483716652_5295902.jpeg, objectUrl=/article/show_article.do?id=041919610548, replyNumber=0, likeNumber=211, createdTime=2020-11-02, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=041919610548, moduleTitle=III期临床试验证明：Dorzagliatin单药治疗2型糖尿病疗效确切, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=041919610548)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Dorzagliatin

2020-05-29

lovetcm (审核中...)

前往app查看评论内容

#Dorzagliatin#

Lancet Diabetes Endo：国产II型糖尿病新药临床效果显著

2020-11-02

lovetcm (审核中...)

前往app查看评论内容

#Dorzagliatin#

中国糖尿病创新药Dorzagliatin达到3期临床主要疗效终点，可降低HbA1c 1.07%

2020-11-02

lovetcm (审核中...)

前往app查看评论内容

#Dorzagliatin#单药治疗#2型糖尿病#

III期临床试验证明：Dorzagliatin单药治疗2型糖尿病疗效确切

2020-11-02

科室
- - 订阅+
  - 更多科室
工具
服务